tetano
Editor, Senior Moderator
BMJ Open
. 2023 Oct 29;13(10):e077911.
doi: 10.1136/bmjopen-2023-077911. Long-term impact of the COVID-19 pandemic on self-management of chronic conditions among high-risk adults in the USA: protocol for the C3 observational cohort study
Rebecca Lovett[SUP] 1 2 3 [/SUP], Sarah Filec[SUP] 2 3 [/SUP], Morgan Bonham[SUP] 2 3 [/SUP], Julia Yoshino Benavente[SUP] 2 3 [/SUP], Rachel O'Conor[SUP] 2 3 [/SUP], Andrea Russell[SUP] 2 3 [/SUP], Pauline Zheng[SUP] 2 3 [/SUP], Guisselle Wismer[SUP] 2 3 [/SUP], Esther Yoon[SUP] 2 3 [/SUP], Sophia Weiner-Light[SUP] 4 2 3 [/SUP], Abigail Vogeley[SUP] 4 2 3 [/SUP], Mary Morrissey Kwasny[SUP] 5 [/SUP], Sarah Lowe[SUP] 6 [/SUP], Laura M Curtis[SUP] 2 3 [/SUP], Alex Federman[SUP] 7 [/SUP], Stacy C Bailey[SUP] 2 3 [/SUP], Michael Wolf[SUP] 2 3 [/SUP]
Affiliations
Introduction: COVID-19 is an unprecedented public health threat in modern times, especially for older adults or those with chronic illness. Beyond the threat of infection, the pandemic may also have longer-term impacts on mental and physical health. The COVID-19 & Chronic Conditions ('C3') study offers a unique opportunity to assess psychosocial and health/healthcare trajectories over 5 years among a diverse cohort of adults with comorbidities well-characterised from before the pandemic, at its onset, through multiple surges, vaccine rollouts and through the gradual easing of restrictions as society slowly returns to 'normal'.
Methods and analysis: The C3 study is an extension of an ongoing longitudinal cohort study of 'high-risk' adults (aged 23-88 at baseline) with one or more chronic medical conditions during the COVID-19 pandemic. Five active studies with uniform data collection prior to COVID-19 were leveraged to establish the C3 cohort; 673 adults in Chicago were interviewed during the first week of the outbreak. The C3 cohort has since expanded to include 1044 participants across eight survey waves (T[SUB]1[/SUB]-T[SUB]8[/SUB]). Four additional survey waves (T[SUB]9[/SUB]-T[SUB]12[/SUB]) will be conducted via telephone interviews spaced 1 year apart and supplemented by electronic health record and pharmacy fill data, for a total of 5 years of data post pandemic onset. Measurement will include COVID-19-related attitudes/behaviours, mental health, social behaviour, lifestyle/health behaviours, healthcare use, chronic disease self-management and health outcomes. Mental health trajectories and associations with health behaviours/outcomes will be examined in a series of latent group and mixed effects modelling, while also examining mediating and moderating factors.
Ethics and dissemination: This study was approved by Northwestern University's Feinberg School of Medicine Institutional Review Board (STU00215360). Results will be published in international peer-reviewed journals and summaries will be provided to the funders of the study.
Keywords: COVID-19; EPIDEMIOLOGIC STUDIES; MENTAL HEALTH; Patient Reported Outcome Measures; Public health.
. 2023 Oct 29;13(10):e077911.
doi: 10.1136/bmjopen-2023-077911. Long-term impact of the COVID-19 pandemic on self-management of chronic conditions among high-risk adults in the USA: protocol for the C3 observational cohort study
Rebecca Lovett[SUP] 1 2 3 [/SUP], Sarah Filec[SUP] 2 3 [/SUP], Morgan Bonham[SUP] 2 3 [/SUP], Julia Yoshino Benavente[SUP] 2 3 [/SUP], Rachel O'Conor[SUP] 2 3 [/SUP], Andrea Russell[SUP] 2 3 [/SUP], Pauline Zheng[SUP] 2 3 [/SUP], Guisselle Wismer[SUP] 2 3 [/SUP], Esther Yoon[SUP] 2 3 [/SUP], Sophia Weiner-Light[SUP] 4 2 3 [/SUP], Abigail Vogeley[SUP] 4 2 3 [/SUP], Mary Morrissey Kwasny[SUP] 5 [/SUP], Sarah Lowe[SUP] 6 [/SUP], Laura M Curtis[SUP] 2 3 [/SUP], Alex Federman[SUP] 7 [/SUP], Stacy C Bailey[SUP] 2 3 [/SUP], Michael Wolf[SUP] 2 3 [/SUP]
Affiliations
- PMID: 37899164
- DOI: 10.1136/bmjopen-2023-077911
Introduction: COVID-19 is an unprecedented public health threat in modern times, especially for older adults or those with chronic illness. Beyond the threat of infection, the pandemic may also have longer-term impacts on mental and physical health. The COVID-19 & Chronic Conditions ('C3') study offers a unique opportunity to assess psychosocial and health/healthcare trajectories over 5 years among a diverse cohort of adults with comorbidities well-characterised from before the pandemic, at its onset, through multiple surges, vaccine rollouts and through the gradual easing of restrictions as society slowly returns to 'normal'.
Methods and analysis: The C3 study is an extension of an ongoing longitudinal cohort study of 'high-risk' adults (aged 23-88 at baseline) with one or more chronic medical conditions during the COVID-19 pandemic. Five active studies with uniform data collection prior to COVID-19 were leveraged to establish the C3 cohort; 673 adults in Chicago were interviewed during the first week of the outbreak. The C3 cohort has since expanded to include 1044 participants across eight survey waves (T[SUB]1[/SUB]-T[SUB]8[/SUB]). Four additional survey waves (T[SUB]9[/SUB]-T[SUB]12[/SUB]) will be conducted via telephone interviews spaced 1 year apart and supplemented by electronic health record and pharmacy fill data, for a total of 5 years of data post pandemic onset. Measurement will include COVID-19-related attitudes/behaviours, mental health, social behaviour, lifestyle/health behaviours, healthcare use, chronic disease self-management and health outcomes. Mental health trajectories and associations with health behaviours/outcomes will be examined in a series of latent group and mixed effects modelling, while also examining mediating and moderating factors.
Ethics and dissemination: This study was approved by Northwestern University's Feinberg School of Medicine Institutional Review Board (STU00215360). Results will be published in international peer-reviewed journals and summaries will be provided to the funders of the study.
Keywords: COVID-19; EPIDEMIOLOGIC STUDIES; MENTAL HEALTH; Patient Reported Outcome Measures; Public health.